New research from Glenmark Pharmaceuticals, conducted among more than 1,000 UK adults, has found that 48 per cent of those who travel to areas at risk of malaria may be leaving themselves exposed to the potentially fatal disease. This is often due to a lack of knowledge about it or because they run out of time to get a prescription before they go.
Aiming to make antimalarial medication more widely available, Glenmark has launched Maloff Protect, the first antimalarial available directly from pharmacy without a prescription. Each tablet contains atovaquone (250mg) and proguanil (100mg), which work by killing malaria parasites in the liver and bloodstream. Maloff Protect needs to be taken one or two days before departure and for seven days after return, plus once a day (taken at the same time each day) during the trip.
Glenmark has also launched “Off Somewhere”, a campaign encouraging travellers to be aware of the risks of malaria on their trips and the steps they can take to #BeMozzieReady.
Toby Stoddart, senior marketing manager for Glenmark Pharmaceuticals Europe, says: “By supporting pharmacists to provide Maloff Protect to their customers directly, we are ensuring more convenient access to antimalarials and saving customers time before they travel. We hope that our nationwide multi-channel activity will drive more travellers into local pharmacies and bolster the role of the pharmacy team when it comes to travel health.”
For more information, visit: maloffprotect.co.uk